We are live on ! Find out more
X

Xponance Portfolio holdings

AUM $16.3B
1-Year Est. Return 44.61%
This Fund
S&P 500
This Quarter Est. Return
+6.8%
1 Year Est. Return
+44.61%
3 Year Est. Return
+143.93%
5 Year Est. Return
+195.59%
10 Year Est. Return
+501.04%
AUM
$9.78B
AUM Growth
+$239M
Cap. Flow
-$199M
Cap. Flow %
-2.04%
Top 10 Hldgs %
39.84%
Holding
1,386
New
76
Increased
471
Reduced
763
Closed
70

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$24.4M
2
ORCL icon
Oracle
ORCL
+$10.8M
3
AMZN icon
Amazon
AMZN
+$10.3M
4
COST icon
Costco
COST
+$7.38M
5
XOM icon
ExxonMobil
XOM
+$6.78M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$32.3M
2
ACN icon
Accenture
ACN
+$18.1M
3
ABBV icon
AbbVie
ABBV
+$14.4M
4
TMO icon
Thermo Fisher Scientific
TMO
+$13.3M
5
CAT icon
Caterpillar
CAT
+$10.7M

Sector Composition

Rank Sector Weight
1 Technology 37.1%
2 Consumer Discretionary 11.12%
3 Healthcare 10.76%
4 Financials 10.45%
5 Communication Services 10.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WHD icon
1151
Cactus
WHD
$4.82B
$220K ﹤0.01%
+4,170
New +$212K
ALGM icon
1152
Allegro MicroSystems
ALGM
$6.66B
$220K ﹤0.01%
7,782
-7,576
-49% -$216K
PRMW
1153
DELISTED
Primo Water Corporation
PRMW
$219K ﹤0.01%
+10,003
New +$206K
STNE icon
1154
StoneCo
STNE
$2.2B
$219K ﹤0.01%
18,236
+485
+3% +$7.15K
KAI icon
1155
Kadant
KAI
$3.53B
$219K ﹤0.01%
744
+37
+5% +$10.5K
ESI icon
1156
Element Solutions
ESI
$8.28B
$218K ﹤0.01%
8,042
+4
+0% +$98
AXNX
1157
DELISTED
Axonics, Inc. Common Stock
AXNX
$217K ﹤0.01%
3,231
+225
+7% +$15.2K
PBH icon
1158
Prestige Consumer Healthcare
PBH
$2.47B
$216K ﹤0.01%
3,142
+114
+4% +$7.72K
CTRE icon
1159
CareTrust REIT
CTRE
$9.25B
$216K ﹤0.01%
+8,614
New +$213K
GH icon
1160
Guardant Health
GH
$21.9B
$216K ﹤0.01%
+7,479
New +$174K
LBRT icon
1161
Liberty Energy
LBRT
$3.11B
$216K ﹤0.01%
10,331
+324
+3% +$7.23K
SHAK icon
1162
Shake Shack
SHAK
$2.8B
$216K ﹤0.01%
2,395
+103
+4% +$10.1K
MAC icon
1163
Macerich
MAC
$6.77B
$213K ﹤0.01%
13,790
+587
+4% +$8.98K
HASI icon
1164
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$5.17B
$210K ﹤0.01%
+7,109
New +$208K
APLE icon
1165
Apple Hospitality REIT
APLE
$3.9B
$210K ﹤0.01%
14,469
+1,310
+10% +$19.5K
IRTC icon
1166
iRhythm Holdings
IRTC
$3.95B
$210K ﹤0.01%
1,954
+94
+5% +$9.6K
ABCB icon
1167
Ameris Bancorp
ABCB
$5.74B
$210K ﹤0.01%
+4,177
New +$200K
SEE
1168
DELISTED
Sealed Air
SEE
$210K ﹤0.01%
6,042
-6,338
-51% -$226K
MHO icon
1169
M/I Homes
MHO
$3.8B
$210K ﹤0.01%
1,718
+80
+5% +$9.78K
DIOD icon
1170
Diodes
DIOD
$4.01B
$209K ﹤0.01%
2,899
-556
-16% -$39.9K
SMPL icon
1171
Simply Good Foods
SMPL
$956M
$208K ﹤0.01%
+5,756
New +$206K
SKYW icon
1172
Skywest
SKYW
$3.82B
$207K ﹤0.01%
+2,517
New +$188K
ADMA icon
1173
ADMA Biologics
ADMA
$2.1B
$206K ﹤0.01%
18,468
+5,597
+43% +$47K
TNET icon
1174
TriNet
TNET
$3.27B
$206K ﹤0.01%
2,062
-1,452
-41% -$162K
CCC
1175
CCC Intelligent Solutions
CCC
$4.46B
$206K ﹤0.01%
18,533
+57
+0.3% +$649

Similar funds

Xponance's Q2 2024 Portfolio in Review

As of Q2 2024, Xponance held 1,386 positions worth $9.78B, up 2.5% from $9.54B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Xponance's Q2 2024 filing shows 76 new, 471 increased, 763 reduced and 70 closed positions. Its largest new stake was GE Vernova: 36,466 shares worth $6.25M. The largest sale was UnitedHealth, an estimated $32.3M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 34% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Xponance's largest Q2 2024 buy was GE Vernova: 36,466 shares worth $6.25M.
  • Xponance added most to Merck in Q2 2024, an estimated $24.4M increase.
  • Xponance's biggest Q2 2024 reduction was UnitedHealth, cutting an estimated $32.3M.
  • Xponance fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $8.15M.
  • Xponance's ten largest holdings make up 40% of its $9.78B portfolio in Q2 2024.
  • Xponance opened 76 new positions and closed 70 in Q2 2024.
  • Xponance's portfolio value rose 2.5% quarter-over-quarter to $9.78B.

Based on Xponance's 13F filing for Q2 2024, filed 14 Aug 2024.